Volume 18 - Issue 1 - January 2005
Fungal infections of the foot represent the fourth most common problem that we see in podiatric practice.1 Approximately 26.5 million people are affected annually.2 Nearly half of these people will suffer from multiple episodes for years. Treatment varies from home remedies and OTC preparations to a large variety of topical and oral medications. While tinea pedis is certainly is not the most challenging condition we treat, eliminating a longstanding, annoying and embarrassing condition can make the practitioner a hero in the eyes of his or her patient.
Editor's Perspective »
What happens when a patient’s family history falls through the cracks? A leading podiatric educator recalls an incident that happened early in his practice. A patient underwent extensive ankle surgery and had a myocardial infarction on the operating table while he was under general anesthesia. The patient survived and the DPM found out later that the patient had a long family history of heart disease.
“From then on, I was very diligent in obtaining the (family history) information from all patients,” he emphasizes.
Fridays are the usual days for eruptions in my podiatry clinic. Friday afternoons are the most typical times when Murphy’s Law rules. An eruption is a diabetic patient with a severe infection or an osteotomy that falls apart or a pin tract infection. If patients hate a new pair of orthotics, they usually show up Friday afternoon to give me an earful.
Last Friday was no exception to the eruption rule but the fun started early. Fridays are always busy in our clinic. My schedule was booked solid with mostly straightforward podiatric cases. Then the emerge
Diabetes Watch »
Management of the diabetic foot is a tremendous challenge. It has been estimated that the annual healthcare costs of caring for the diabetic foot range in the billions.1 Approximately 15 percent of diabetic patients will develop a foot or leg ulceration at some point during the course of their disease and 50 percent of those patients suffer reulceration within 18 months.2 Researchers have observed that the prevalence of neuropathy in the diabetic population is 33.5 percent, the prevalence of vascular disease is 12.7 percent and the prevalence of foot ulc
Diagnostic Dilemmas »
In 1876, Morton described a peculiar and painful affliction of the foot in the area of the fourth and fifth metatarsals as the metatarsals compress the plantar interdigital nerve. Describing this as a neuroma is bit of a misnomer as the condition is more likely an entrapment rather than a true neuroma. The effects of compression on nerve fibers are extensive. Nerve compression can be from external edema surrounding the nerve, edema within the nerve or external compression from other anatomical structures in the area.
It may be more appropriate to refer t
News and Trends »
In the past, the majority of comparative studies of antibiotics for diabetic foot infections have been relegated to smaller, unblinded trials. However, a new randomized, multicenter study of over 500 patients found that the simpler dosing regimen of ertapenem (Invanz, Merck) had comparable results to piperacillin/tazobactam in treating these infections.
In what study co-author David G. Armstrong, DPM, MSc, PhD, calls “easily the largest ever randomized controlled trial of diabetic foot infections,” the double-blinded SIDESTEP Study of Diabetic Foot I
- « Previous
- | Page 1 of 2 |
- Next »